PremiumThe FlyBoeing, Paramount downgraded: Wall Street’s top analyst calls Biotech Sector: M&A Fuels Renewed Excitement Deciphera upgraded to Equal Weight from Underweight at Barclays PremiumThe FlyDeciphera downgraded to Hold from Buy at Jefferies Deciphera downgraded to Neutral from Overweight at Piper Sandler Deciphera to resume trading at 7:30 am ET PremiumPre-EarningsIs DCPH a Buy, Before Earnings? Deciphera presents long-term follow-up results from INTRIGUE Phase 3 trial Deciphera, GENESIS Pharma enter distribution agreement for RIPRETINIB 
